Posted on 3/18/20
Zylotech Names Ernie Cormier as CEO
Zylotech, the customer intelligence platform building strong customer connections for B2B enterprises
Posted on 3/18/20
Akamai Technologies Elects Marianne Brown to Board
Akamai (NASDAQ: AKAM), the intelligent edge platform for securing and delivering digital experiences, today announced the appointment of Marianne Brown
Posted on 3/18/20
Richard D. Booth Joins Charles River Associates Board of Directors
Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, announced that its Board of Directors
Posted on 3/17/20
LogicBio Therapeutics Appoints Mark Enyedy to its Board
LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a genome editing company focused on developing medicines to
Posted on 3/17/20
Michael Shunney Appointed as CEO of The Advocator Group
The Advocator Group, LLC, a nationwide disability advocacy and disability insurance services organization
Posted on 3/17/20
Infinity Pharmaceuticals Appoints Richard Gaynor To Board
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) announced today the appointment of Richard Gaynor, M.D. to its Board of Directors, effective March 16, 2020.“We are thrilled . . .
Posted on 3/17/20
Mike Baker Joins Pixability’s Board of Directors
Pixability, the leading provider of software and insights for video advertising on YouTube and Connected TV, today announced that Mike Baker,
Posted on 3/16/20
Thomas Bartlett Appointed CEO of American Tower
American Tower Corporation (NYSE:AMT) today announced that Jim Taiclet will be transitioning from his roles as President, Chief Executive Officer and executive Chairman of the Board.
Posted on 3/12/20
Dr. Rachel Sherman Joins Sema4 Board of Directors
Sema4, a patient-centered health intelligence company, today announced the appointment of Rachel Sherman, MD, MPH, to its Board of Directors.
Posted on 3/12/20
VBI Vaccines Appoints Damian Braga to Board of Directors
VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines
Posted on 3/11/20
Ambri Elects Lewis Von Thaer to Board
Ambri Inc. announced today that Lewis “Lou” Von Thaer, President and CEO of the Battelle Memorial Institute, has been
Posted on 3/11/20
IDEMIA Joins Kantara Board of Directors
WAKEFIELD, Mass.--(BUSINESS WIRE)--Six new members joined Kantara Initiative including IDEMIA, the global leader in trusted identity, it was announced today. IDEMIA is joining Kantara as a . . .
Posted on 3/11/20
Strand Therapeutics Appoints Dr. Dane Wittrup to Scientific Advisory Board and Dr. Mark Frohlich to Newly Formed Clinical Advisory Board
Dtrand Therapeutics, an mRNA gene therapy company specialized in utilizing synthetic biology for immunotherapy of cancer, announced today the appointment of industry leader
Posted on 3/10/20
Florida Cardiologist Zachariah Zachariah Joins BioSig Technologies Advisory Board
BioSig Technologies, Inc. (NASDAQ: BSGM), a medical technology company commercializing a proprietary biomedical signal processing platform
Posted on 3/10/20
TScan Therapeutics Appoints Douglas Fambrough To Board
TScan Therapeutics, a biopharmaceutical company focused on the development of T cell receptor (TCR) therapies which reprogram a patient’s own T cells
Posted on 3/9/20
PatientKeeper Appoints Philip Meer CEO
PatientKeeper, Inc. today announced the appointment of Philip Meer as Chief Executive Officer. Meer brings to PatientKeeper 20 years of experience in customer-facing leadership
Posted on 3/9/20
Invest in Others Charitable Foundation Elects 2020 Executive Committee and New Board Members
The Invest in Others Charitable Foundation announces the election of its 2020 Executive Committee and three new members to its Board of Directors.
Posted on 3/8/20
Covetrus Names Benjamin Wolin CEO
Covetrus (Nasdaq: CVET), a global leader in animal-health technology and services, today announced that Benjamin Wolin will become the company's president
Posted on 3/6/20
New England Peptide Appoints Martina Diekmann as CEO
New England Peptide, a leading provider of peptides for pharmaceutical research and development, which recently acquired Peptides International,
Posted on 3/5/20
Aspen Technology Appoints Adriana Karaboutis to Board
Aspen Technology, Inc. (NASDAQ: AZPN), a global leader in asset optimization software, today announced that Adriana Karaboutis will join the Aspen Technology board
Posted on 3/4/20
Fusion Pharmaceuticals Appoints Steven Gannon to Board of Directors
Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radio pharmaceuticals as precision medicines
Posted on 3/4/20
Charles River Laboratories Adds Nancy C. Andrews, M.D., Ph.D., to Board of Directors
Charles River Laboratories International, Inc. (NYSE: CRL) today announced the appointment of Nancy C. Andrews, M.D., Ph.D., to its Board of Directors
Posted on 3/4/20
Christine R. Detrick Joins Charles River Associates (CRA) Board of Directors
Charles River Associates (NASDAQ: CRAI), a worldwide leader in providing economic, financial, and management consulting services, announced that its Board of Directors
Posted on 3/4/20
GE Nominates Ashton Carter to the Board of Directors
GE (NYSE:GE) today announced that its Board of Directors will nominate former U.S. Secretary of Defense Ashton (Ash) Carter to the GE Board
Posted on 3/4/20
Relay Therapeutics Announces Formation of Oncology Advisory Board
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Relay Therapeutics, a new breed of company at the intersection of computation and biotechnology, announced today the appointment of top oncology experts, scientists and . . .
Boston
